These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9097868)
21. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Ray LA; Hutchison KE Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272 [TBL] [Abstract][Full Text] [Related]
22. Does adding low doses of oral naltrexone to morphine alter the subsequent opioid requirements and side effects in trauma patients? Farahmand S; Ahmadi O; Dehpour A; Khashayar P Am J Emerg Med; 2012 Jan; 30(1):75-8. PubMed ID: 21075578 [TBL] [Abstract][Full Text] [Related]
24. Opiate antagonists and eating behavior in humans: a review. de Zwaan M; Mitchell JE J Clin Pharmacol; 1992 Dec; 32(12):1060-72. PubMed ID: 1487543 [TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis. Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506 [TBL] [Abstract][Full Text] [Related]
26. Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature. Brewer C; Wong VS Addict Biol; 2004 Mar; 9(1):81-7. PubMed ID: 15203443 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814 [TBL] [Abstract][Full Text] [Related]
28. Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option? Ramanathan S; Panksepp J; Johnson B Psychosomatics; 2012; 53(6):591-4. PubMed ID: 22480625 [No Abstract] [Full Text] [Related]
29. Treatment of pruritus with topically applied opiate receptor antagonist. Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241 [TBL] [Abstract][Full Text] [Related]
31. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study. Willemsen-Swinkels SH; Buitelaar JK; van Engeland H Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837 [TBL] [Abstract][Full Text] [Related]
32. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients. Setnik B; Roland CL; Goli V; Sommerville K; Webster L J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323 [TBL] [Abstract][Full Text] [Related]
33. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex. Chindalore VL; Craven RA; Yu KP; Butera PG; Burns LH; Friedmann N J Pain; 2005 Jun; 6(6):392-9. PubMed ID: 15943961 [TBL] [Abstract][Full Text] [Related]
35. Strategies to maximize the efficacy of naltrexone for alcohol dependence. O'Malley SS NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772 [No Abstract] [Full Text] [Related]
36. Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability. Turel AP; Oh KH; Zagon IS; McLaughlin PJ J Clin Psychopharmacol; 2015 Oct; 35(5):609-11. PubMed ID: 26203498 [No Abstract] [Full Text] [Related]
37. The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone. Jonas JM; Gold MS Psychiatry Res; 1988 May; 24(2):195-9. PubMed ID: 2841709 [TBL] [Abstract][Full Text] [Related]
38. ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety. Katz N; Sun S; Johnson F; Stauffer J J Pain; 2010 Apr; 11(4):303-11. PubMed ID: 19944650 [TBL] [Abstract][Full Text] [Related]